VYGR — Voyager Therapeutics Share News
0.000.00%
Last trade - 00:00- $107.22m
- -$9.12m
- $40.37m
Brief: Voyager Therapeutics Announces First Participants Dosed In Dose Trial Of Vy-Tau01 For Treatment Of Alzheimer’s Disease
Voyager Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Voyager Therapeutics Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: Voyager Therapeutics Presents Data For Second-Generation, Tracer™-Generated Capsids And Cns Gene Therapy Programs Advancing Toward Clinical Trials At The Asgct 27Th Annual Meeting
Voyager Therapeutics Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: Voyager Therapeutics Says Peter P. Pfreundschuh Resigned From His Position Of Chief Financial Officer Effective On April 12, 2024
U.S. STOCKS ON THE MOVE-Boeing, Chemours, C3.ai
U.S. STOCKS ON THE MOVE-Voyager Therapeutics, GoodRx Holdings, Tenet Healthcare
Voyager Therapeutics rises on upbeat Q4 earnings
Voyager Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Voyager Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet
Voyager becomes eligible for milestone payment of $5 mln, shares rise
Brief: Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia with Neurocrine Biosciences
Brief: Voyager Therapeutics Reports Robust Preclinical Activity In TAU Silencing Gene Therapy Program For Alzheimer’S And Advances Program Into Late Research
U.S. STOCKS ON THE MOVE-CVS Health, Peloton, Eli Lilly
U.S. STOCKS ON THE MOVE-Conagra Brands, Voyager Therapeutics, McDonald's